Error: Could not add to watchlist. X

Alexion Pharmaceuticals Inc

+ Watchlist
ALXN:US
NASDAQ GS
199.72
USD
1.62
0.82%
As of 09:48:15 ET on 07/28/2015.
Open
200.22
Day Range
198.60 - 200.56
Volume
63,579
Previous Close
198.10
52Wk Range
150.06 - 208.88
1 Yr Return
22.74%
Open
200.22
Day Range
198.60 - 200.56
Volume
63,579
Previous Close
198.10
52Wk Range
150.06 - 208.88
1 Yr Return
22.74%
YTD Return
7.96%
Current P/E Ratio (TTM)
63.45
Earnings per Share (USD) (TTM)
3.12
Market Cap (b USD)
43.700
Shares Outstanding (m)
220.598
Price/Sales (TTM)
17.49
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company develops C5 complement inhibitors and Apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.
ADDRESS
352 Knotter Drive
Cheshire, CT 06410
United States
PHONE
1-203-272-2596
  • David L Hallal
    Chief Executive Officer
  • Vikas Sinha
    Exec VP/CFO
  • Saqib Islam
    Exec VP/Chief Strategy Officer
  • Dominique Monnet
    Exec VP/Chief Mktg Officer
  • Clare Carmichael
    Exec VP/Chief Human Resource Ofcr
Show More